Unlocking Potential. Driving Innovation. Empowering Growth. Discover our comprehensive services designed to support early to mid-stage companies in the energy, healthcare, medical cannabis industries and AI technologies.
Partnering for Success
Investments Strategy
Wood Capital prefers to invest in small and middle market operating companies, targeting equity investments generally up to $10 million in companies with revenues generally between $10 million and $50 million. The firm pursues opportunities where it can provide meaningful value to a management team through previous industry experience. Wood Capital is also interested in control investments in management buyouts and recapitalization transactions, or select minority equity investments in companies which coincide with our areas of expertise.
Investments Criteria
- Industries in which the firm’s principals have significant operating experience
- Strong incumbent management team with a vision for the future of their company
- Industries with attractive long-term growth trends
- Critical supply relationships with customers
- Potentially out-of-favor industries with improving prospects
- Fragmented industries, which can benefit from consolidation
- Sustainable barriers to entry
Notable Investments
Introducing Our Portfolio of Transformative Ventures
Wood Capital takes great pride in our diverse portfolio of transformative ventures that are shaping industries and driving innovation. Among our notable investments, we have strategically focused on the medical cannabis market, recognizing its immense potential for growth and impact. Our commitment to supporting visionary companies in this sector has positioned us at the forefront of the evolving landscape.
Leading the Way in the Canadian Medical Cannabis Market
Jed Wood, president of Wood Capital was a critical early-stage investor in the Canadian, US, and UK medical cannabis industry, funding corporations and early-stage founders, in addition to providing business, operational, and entrepreneurial advice and experience in helping develop the sector.
The Canadian industry had many barriers and challenges before successfully developing into the largest and most capitalized cannabis market in the world. Access to capital and business/operational advice was very limited and Jed Wood, president of Wood Capital was critical to these companies surviving, developing, and maturing. Wood Capital and related parties have generated more than US$100M in the fair market value of its investments in the sector.
Wood Capital and Jed Wood have been some of the most successful business investors in the sector, spanning three countries (Canada, US, UK), and in four companies that were critical to the success of the sector. The experience gained from successful capital markets, operational, business, and medical research in this sector over the last decade is a valuable and unique asset.
Prior Investments
Mr. Wood also provides financing for the following companies:
- Q5iD, the future of identity management
- Stream Asset Financial L.P., a leading global alternative capital provider
- CorVista Health harnesses the power of AI to reimagine cardiac disease detection
- Wishi Fashion LTD, an e-commerce software company for the fashion industry
- Ardenton, a global portfolio management company with majority ownership interests in portfolio companies in CA, US, and the UK
- Dataminr, one of the world’s leading AI businesses informs clients about high-impact events and emerging risks to mitigate and manage crises more effectively
- Palantir empowers organizations with the ability to create and govern AI across public and private networks
- SkyFish, a drone platform designed to inspect, measure, map, and model critical infrastructure
- Rivers Capital Group provides capital with a preference for businesses that have a commercial real estate component
- Miami Cocktail, a clean craft cocktail RTD CPG company
- Aspire Health Science Inc., developing best-in-class therapies in the fight against cancer, vascular, orthopedic and age-related diseases